Results 11 to 20 of about 4,642,144 (350)
Blood, 2020 The anti-von Willebrand factor nanobody caplacizumab was licensed for adults with immune-mediated thrombotic thrombocytopenic purpura (iTTP) based on prospective controlled trials. However, few data are available on post-marketing surveillance.
P. Coppo +27 more
semanticscholar +1 more source
Plasma exchange in patients with acute and acute-on-chronic liver failure: A systematic review
World Journal of Gastroenterology, 2020 BACKGROUND Acute liver failure (ALF) and acute-on-chronic liver (ACLF) carry high short-term mortality rate, and may result from a wide variety of causes.
E. Tan, Min-Xian Wang, J. Pang, G. Lee
semanticscholar +1 more source
Case Report: High-dose immunoglobulins prior to plasma exchange in severe pulmonary renal syndrome
Frontiers in Immunology, 2023 Plasma exchange rapidly depletes pathogenic anti-neutrophil cytoplasmic autoantibodies (ANCAs) and is considered for induction therapy in severe ANCA-associated vasculitis.
Ann-Kathrin Schäfer +5 more
doaj +1 more source
Alzheimer's & Dementia, 2020 This phase 2b/3 trial examined the effects of plasma exchange (PE) in patients with mild‐to‐moderate Alzheimer's disease (AD).
M. Boada +18 more
semanticscholar +1 more source
Therapeutic Plasma Exchange Using Membrane Plasma Separation.
American Society of Nephrology. Clinical Journal, 2020 Therapeutic plasma exchange is a blood purification technique designed for the removal of large molecular weight toxins such as pathogenic antibodies and lipoproteins.
Sadiq Ahmed, A. Kaplan
semanticscholar +1 more source
Efficacy of therapeutic plasma exchange in severe COVID‐19 patients
British Journal of Haematology, 2020 Coronavirus disease 2019 (COVID-19) could lead to a sharp increase in the levels of inflammatory cytokines. We report the efficacy of therapeutic plasma exchange in severe COVID-19 patients with acute respiratory distress syndrome.
Li Zhang +4 more
semanticscholar +1 more source
Efficacy and safety of plasma exchange for Kawasaki disease with coronary artery dilatation
Renal Replacement Therapy, 2017 Background The treatment of Kawasaki disease is controversial when intravenous immunoglobulin therapy fails, although it typically relies on combinations of prednisolone, infliximab, cyclosporine, and plasma exchange therapy. The goal of the treatment is
Yusuke Kaida +12 more
doaj +1 more source
Increased plasma viscosity as a reason for inappropriate erythropoietin formation [PDF]
, 1993 The aim of this study was to examine whether altered plasma viscosity could contribute to the inappropriately low production rate of erythropoietin (EPO) observed in patients suffering from hypergammaglobulinemias associated with multiple myeloma or ...
Eckardt, Kai-Uwe +7 more
core +2 more sources
Therapeutic plasma exchange for COVID‐19‐associated hyperviscosity
Transfusion, 2020 Recent data suggests an association between blood hyperviscosity and both propensity for thrombosis and disease severity in patients with COVID‐19. This raises the possibility that increased viscosity may contribute to endothelial damage and multiorgan ...
Alexander D. Truong +19 more
semanticscholar +1 more source
The role of charge-exchange processes in probing hydrogen plasma with a heavy ion beam
Matter and Radiation at Extremes, 2023 Charge-changing processes of low-charged ions, used in hydrogen plasma probing by the heavy ion beam probe method, are considered. Along with the ionization of beam ions by plasma electrons and protons, the charge-exchange processes of ions on H atoms ...
Inga Yu Tolstikhina, V. P. Shevelko
doaj +1 more source